Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-02-001025
Filing Date
2002-10-04
Accepted
2002-10-04 11:24:38
Documents
1
Period of Report
2002-10-03

Document Format Files

Seq Description Document Type Size
1 doc1.txt 4 8331
  Complete submission text file 0001144204-02-001025.txt   10221
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 4152444990
TITAN PHARMACEUTICALS INC (Subject) CIK: 0000910267 (see all company filings)

EIN.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-13341 | Film No.: 02781637
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address
Business Address C/O TITAN PHARMACEUTICALS INC 400 OYSTER POINT BLVD SUITE 505 SOUTH SAN FRANCISCO CA 94080 6502444990
VALONE FRANK H MD (Reporting) CIK: 0001182657 (see all company filings)